RT
Regor Therapeutics is a biotech company focused on developing targeted therapies for oncology, metabolic, and autoimmune diseases using advanced drug discovery techniques. The company aims to improve patient outcomes by addressing the unmet medical needs in these therapeutic areas through precision medicine approaches.
Updated 20 months ago
Funding
$50M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EL
Funding rounds are not available yet.
Founders
Product
Features
- Regor Therapeutics is a biotech company focused on developing targeted therapies for oncology, metabolic, and autoimmune diseases using advanced drug discovery techniques. The company aims to improve patient outcomes by addressing the unmet medical needs in these therapeutic areas through precision medicine approaches.